FLOMENBERG NEAL (Chief Scientific Officer) received a stock award from TEVOGEN BIO HOLDINGS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/1/2025ACC: 0001062993-25-012329
Officer· Chief Scientific Officer
Since Feb 2024
+300K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
300K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+300K
Price / share
—
Trade value
—
% of position
8.3%
6/27/2025
3.60M→3.90M
Total
Net shares
+300K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/27/2025 | A · Award | +300K | — | — | 8.3% | 3.60M | 3.90M |
| Total | +300K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported